Report overview
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
This report contains market size and forecasts of Hepatitis A Vaccine in global, including the following market information:
Global Hepatitis A Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hepatitis A Vaccine Market Sales, 2017-2022, 2023-2028, (K Unit)
Global top five Hepatitis A Vaccine companies in 2021 (%)
The global Hepatitis A Vaccine market was valued at 726.3 million in 2021 and is projected to reach US$ 842.5 million by 2028, at a CAGR of 2.1% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inactivated Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis A Vaccine include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS and Convac. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis A Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis A Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Unit)
Global Hepatitis A Vaccine Market Segment Percentages, by Type, 2021 (%)
Inactivated Vaccine
Live Attenuated Vaccine
Global Hepatitis A Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Unit)
Global Hepatitis A Vaccine Market Segment Percentages, by Application, 2021 (%)
Government Institution
Private Sector
Other
Global Hepatitis A Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Unit)
Global Hepatitis A Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis A Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hepatitis A Vaccine revenues share in global market, 2021 (%)
Key companies Hepatitis A Vaccine sales in global market, 2017-2022 (Estimated), (K Unit)
Key companies Hepatitis A Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
KM Biologics
IMBCAMS
Convac
